WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. ("Eagle") (NASDAQ:EGRX) announced that the Company will present at the 39th Annual Deutsche Bank Health Care Conference on May 7 – 8, 2014 at the InterContinental Hotel in Boston, MA.
Scott Tarriff, President and Chief Executive Officer, and David E. Riggs, Chief Financial Officer, will host the presentation on Thursday, May 8, 2014 at 3:30 p.m. EDT.
To listen to the webcast of this presentation during the event, please visit: http://www.media-server.com/m/p/6y5jmyqo . A replay of this webcast will be available for 30 days after the initial presentation.
ABOUT EAGLE
Eagle is a specialty pharmaceutical company focused on developing and commercializing injectable products utilizing the FDA's 505(b)(2) regulatory pathway. The Company develops products that address the shortcomings, as identified by physicians, pharmacists and other stakeholders, of existing commercially successful injectable products.
Eagle Pharmaceuticals, Inc.
David E. Riggs, 201-326-5300
Chief Financial Officer
driggs@eagleus.com
or
In-Site Communications, Inc.
Lisa M. Wilson, 212-452-2793
lwilson@insitecony.com